More on CELG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/23/15 *Est.)
- M&A (12/31/15 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CELG Income Statement

Click line-items for a historical chart and %
Revenue:
Net product sales 2.25B
Collaborative agreements and other revenue 23.7M
Royalty revenue
Total revenue 2.28B
Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 1.11B
Selling, general and administrative 616.8M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net -29.3M
Total costs and expenses 1.86B
Operating income 415.8M
Other income and expense:
Interest and investment income, net 8.8M
Equity in (gains) losses of affiliated companies
Interest expense -48.3M
Other income, net 94.5M
Income before income taxes 470.8M
Income tax provision 114.6M
Net income 356.2M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 0.45
Diluted 0.43
Weighted average shares:
Basic 793M
Diluted 825.3M